The future role of CMR in IHD-Topic Video

Video Transcription

Video Summary

The speaker argues provocatively that CMR may have no future role in ischemic heart disease because CT angiography, CT-FFR, and CT perfusion are faster and simpler. He notes that trials like COURAGE and FAME support avoiding revascularization in patients without significant ischemia, while the true ischemic threshold for benefit remains unclear. The main future role for CMR, he says, is in proving which patients should be revascularized, helping define prognostic ischemic burden, and doing so with the best available noninvasive test. He highlights CMR’s strengths: high spatial resolution, 3D imaging, and strong performance versus SPECT and often PET. However, major challenges remain in quantification, validation, and standardization across sequences and techniques. Ongoing and planned trials such as MR INFORM, ischemia trials, and CMR-guided studies are expected to clarify CMR’s role in guiding treatment decisions.

Keywords

CMR

ischemic heart disease

CT angiography

myocardial ischemia

revascularization